These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3485064)

  • 1. Outpatient esophageal variceal sclerotherapy: safe and cost-effective. A prospective study.
    Korula J
    Gastrointest Endosc; 1986 Feb; 32(1):1-3. PubMed ID: 3485064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed perforation of the esophagus after variceal sclerotherapy and hepatic transplantation.
    Vickers CR; O'Connor HJ; Quintero GA; Aerts RJ; Elias E; Neuberger JM
    Gastrointest Endosc; 1989; 35(5):459-61. PubMed ID: 2792686
    [No Abstract]   [Full Text] [Related]  

  • 3. Outpatient endoscopic injection sclerosis of esophageal varices.
    Drell E; Prindiville T; Trudeau W
    Gastrointest Endosc; 1986 Feb; 32(1):4-6. PubMed ID: 3949132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sodium tetradecyl sulfate endoscopic variceal sclerotherapy on the esophagus. A prospective clinical and histopathologic study.
    Kage M; Korula J; Harada A; Mucientes F; Kanel G; Peters RL
    J Clin Gastroenterol; 1987 Dec; 9(6):635-43. PubMed ID: 3443730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 1% sodium tetradecyl sulfate to a thrombogenic sclerosant cocktail for endoscopic sclerotherapy.
    Lyons SD; Sugawa C; Geller ER; Vandenberg DM
    Am Surg; 1988 Feb; 54(2):81-4. PubMed ID: 3257666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerotherapy for esophageal varices--a prospective study.
    Trivedi DR; Kale CH; Trivedi V; Patkar AP; Dubash C
    Indian J Gastroenterol; 1986 Oct; 5(4):293. PubMed ID: 3781587
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sodium tetradecyl sulfate as a sclerosing solution in the therapy of esophageal varices].
    Ohashi M; Iwase H; Horiguchi H; Nakane M; Nagata J
    Nihon Rinsho; 1990 Apr; 48(4):722-6. PubMed ID: 2366359
    [No Abstract]   [Full Text] [Related]  

  • 8. Endoscopic variceal sclerotherapy as primary treatment for bleeding esophageal varices.
    Low DE; Kozarek RA; Ball TJ; Beebe HG
    J Clin Gastroenterol; 1989 Jun; 11(3):253-9. PubMed ID: 2787818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of stricture formation after endoscopic sclerotherapy of esophageal varices.
    Snady H; Rosman AS; Korsten MA
    Gastrointest Endosc; 1989; 35(5):377-80. PubMed ID: 2792671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oesophageal varices treated by sclerotherapy: a histopathological study.
    Evans DM; Jones DB; Cleary BK; Smith PM
    Gut; 1982 Jul; 23(7):615-20. PubMed ID: 6979497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies in sclerotherapy: I. Comparison of sodium tetradecyl sulphate (STS) with absolute alcohol (AA) as sclerosants in the treatment of esophageal varices.
    Chawla Y; Dilawari JB
    J Clin Gastroenterol; 1990 Aug; 12(4):378-80. PubMed ID: 2398244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, randomized trial of hypertonic glucose water and sodium tetradecyl sulfate for gastric variceal bleeding in patients with advanced liver cirrhosis.
    Chang KY; Wu CS; Chen PC
    Endoscopy; 1996 Aug; 28(6):481-6. PubMed ID: 8886633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate.
    Sung JJ; Yeo W; Suen R; Lee YT; Chung SC; Chan FK; Johnson PJ
    Gastrointest Endosc; 1998 Mar; 47(3):235-9. PubMed ID: 9540875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerotherapy in noncirrhotic portal fibrosis.
    Chawla YK; Dilawari JB; Dhiman RK; Goenka MK; Bhasin DK; Kochhar R; Singh K; Kaur U
    Dig Dis Sci; 1997 Jul; 42(7):1449-53. PubMed ID: 9246045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent endoscopic variceal sclerotherapy increases risk of complications. Prospective randomized controlled study of two treatment schedules.
    Akriviadis E; Korula J; Gupta S; Ko Y; Yamada S
    Dig Dis Sci; 1989 Jul; 34(7):1068-74. PubMed ID: 2787232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injection sclerotherapy preceded by esophageal tamponade versus immediate sclerotherapy in arresting active variceal bleeding: a prospective randomized trial.
    Lo GH; Lai KH; Ng WW; Tam TN; Lee SD; Tsai YT; Lo KJ
    Gastrointest Endosc; 1992; 38(4):421-4. PubMed ID: 1511814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized comparison of esophageal variceal sclerotherapy agents: sodium tetradecyl sulfate versus sodium morrhuate.
    McClave SA; Kaiser SC; Wright RA; Edwards JL; Kranz KR
    Gastrointest Endosc; 1990; 36(6):567-71. PubMed ID: 2279644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perforation after endoscopic injection sclerotherapy for bleeding gastric varices.
    Ng EK; Chung SC; Leong HT; Li AK
    Surg Endosc; 1994 Oct; 8(10):1221-2. PubMed ID: 7809810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic sclerotherapy for bleeding esophageal varices secondary to extrahepatic portal vein obstruction.
    Thatcher BS; Sivak MV; Petrini JL
    Gastrointest Endosc; 1987 Jun; 33(3):214-9. PubMed ID: 3596187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of paraesophageal varices and gastric varices in patients achieving variceal obliteration by banding ligation and by injection sclerotherapy.
    Lo GH; Lai KH; Cheng JS; Huang RL; Wang SJ; Chiang HT
    Gastrointest Endosc; 1999 Apr; 49(4 Pt 1):428-36. PubMed ID: 10202054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.